| Literature DB >> 26257623 |
Svetlana Pundik1, Jessica P McCabe2, Ken Hrovat2, Alice Erica Fredrickson2, Curtis Tatsuoka3, I Jung Feng4, Janis J Daly5.
Abstract
OBJECTIVES: Neuroplastic changes that drive recovery of shoulder/elbow function after stroke have been poorly understood. The purpose of this study was to determine the relationship between neuroplastic brain changes related to shoulder/elbow movement control in response to treatment and recovery of arm motor function in chronic stroke survivors.Entities:
Keywords: chronic stroke; functional Magnetic Resonance Imaging; motor learning; motor recovery; motor rehabilitation; neuroplasticity; shoulder/elbow movement task; upper extremity motor function
Year: 2015 PMID: 26257623 PMCID: PMC4510426 DOI: 10.3389/fnhum.2015.00394
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Figure 1Upper limb training protocol: treatment progression hierarchy for coordinated movement practice. Reproduced with permission of Arch PMR, McCabe et al. (2015).
Figure 2functional Magnetic Resonance Imaging (fMRI) set up. Reproduced with permission of J. Neurosci. Methods, Daly et al. (2008).
Subject characteristics.
| Stroke subjects | |
|---|---|
| Age in years, mean (std dev) | 56.3 (12.8) |
| Female (%) | 41 |
| Stroke hemisphere (% Left) | 55% |
| Stroke Type (% ischemic) | 88.6% |
| Years since stroke | 1.8 (1.1) |
| Lesion location n (%) | |
| BG/IC | 7 (30%) |
| Pons | 2 (8.6%) |
| Frontal lobe | 1 (2.3%) |
| Frontal/parietal lobes | 3 (13%) |
| Frontal lobe/BG/IC | 3 (13%) |
| Frontal/parietal lobes/BG/IC | 5 (21.7%) |
| Frontal/parietal/temporal lobes/BG/IC | 2 (8.6%) |
| Medical history | |
| DM | 17.4% |
| HTN | 52.2% |
| Heart disease | 21.7% |
| Smoking | 56.5% |
Key: BG - basal ganglia, IC - internal capsule, DM - diabetes mellitus, HTN - hypertension.
Figure 3Illustrations of stroke lessions. Right side of each image represents right hemisphere.
Figure 4Average control brain activation map (A); Example of stroke at Pre- Treatment (B) and Post Treatment (C). Left side of each image is contralateral to the moving arm.
For each ROI, comparison of two neuroplastic patterns, according to baseline motor function (AMAT).
| Neuroplastic Pattern 1 (increased fMRI activation after treatment) | Neuroplastic Pattern 2 (decreased or unchanged fMRI activation after treatment) | |||||
|---|---|---|---|---|---|---|
| ROI | Sample size | AMAT (s) mean (SD) | Sample size | AMAT (s) mean (SD) | Pattern comparison | |
| M1 | 14 | 1927.4 (429) | 9 | 1230.8 (749) | 0.01* | |
| AS | 8 | 1753.7 (418) | 15 | 1602.0 (765) | ns | |
| S1 | 13 | 1914.9 (444) | 10 | 1316.6 (756) | 0.03 | |
| SII | 11 | 1866.0 (484) | 12 | 1461.2 (754) | ns | |
| LPM | 11 | 1919.3 (462) | 12 | 1412.3 (734) | ns | |
| SMA | 11 | 1928.7 (466) | 12 | 1403.7 (725) | 0.05 | |
| M1 | 11 | 1889.9 (492) | 12 | 1439.3 (736) | ns | |
| AS | 7 | 1754.4 (448) | 16 | 1611.2 (741) | ns | |
| S1 | 10 | 1933.0 (491) | 13 | 1440.8 (707) | ns | |
| SII | 9 | 1754.4 (438) | 14 | 1590.8 (777) | ns | |
| LPM | 10 | 1897.4 (461) | 13 | 1468.1 (740) | ns | |
| SMA | 11 | 2043.3 (347) | 12 | 1298.6 (684) | 0.004* | |
Key: *Significant p value after adjustment for multiple comparisons, according to Holm-Bonferroni method; ns, unadjusted p > 0.05; M1, primary motor; SMA, supplementary motor area; LPM, lateral premotor region; S1, primary somatosensory area; SII, secondary sensory region; AS, associative sensory; ROI, region of interest; AMAT, Arm Motor Abilities Test.
For each ROI, comparison of two neuroplastic patterns, according to change in AMAT score in response to rehabilitation.
| Neuroplastic Pattern 1 (increased fMRI activation after treatment) | Neuroplastic Pattern 2 (decreased or unchanged fMRI activation after treatment) | |||||
|---|---|---|---|---|---|---|
| ROI | Sample size | Baseline AMAT (sec)mean (SD) | Sample size | Baseline AMAT (sec)mean (SD) | Pattern comparison | |
| M1 | 14 | 538.0 (386) | 9 | 235.1 (282) | 0.028* | |
| AS | 8 | 549.5 (484) | 15 | 350.1 (299) | ns | |
| S1 | 13 | 556.5 (395) | 10 | 241.3 (274) | 0.015 | |
| SII | 11 | 485.4 (305) | 12 | 359.0 (434) | ns | |
| LPM | 11 | 576.1 (422) | 12 | 275.9 (271) | 0.023 | |
| SMA | 11 | 547.9 (445) | 12 | 301.7 (266) | ns | |
| M1 | 11 | 612.3 (428) | 12 | 242.8 (210) | 0.023 | |
| AS | 7 | 715.9 (433) | 16 | 289.8 (270) | 0.004* | |
| S1 | 10 | 593.7 (441) | 13 | 285.4 (261) | 0.042 | |
| SII | 9 | 609.0 (438) | 14 | 297.6 (283) | 0.028 | |
| LPM | 10 | 595.8 (440) | 13 | 283.8 (260) | 0.049 | |
| SMA | 11 | 564.9 (444) | 12 | 286.2 (250) | ns | |
Key: M1, primary motor; SMA, supplementary motor area; LPM, lateral premotor region; S1, primary somatosensory area; SII, secondary sensory region; AS, associative sensory; *significant p value after adjustment for multiple comparisons, according to Holm-Bonferonni method; ns, non-significant; ROI, region of interest.
Comparison of three neuroplastic patterns (consistency or lack thereof across ROIs), according to baseline AMAT, AMAT gain, time since stroke and age.
| Consistent** increased brain activation across ROI’s after treatment ( | Consistent** decrease (or unchanged) brain activation across ROIs after treatment ( | Mixed neuroplastic pattern across ROIs after treatment ( | ||
|---|---|---|---|---|
| AMAT at baseline (s), mean (SD) | 1691.6(479) | 1070.5(753) | 2041.7(349) | 0.04 |
| AMAT improvement (s), mean (SD) | 693.3(471) | 169.8 (203) | 430(309) | 0.02 |
| Age in years, mean(SD) | 58.17(6.8) | 57.57 (13.6) | 51.7(14.6) | ns |
| Time since stroke, in years, mean(SD) | 2.28(1.5) | 1.99 (1.3) | 1.34(0.4) | ns |
Key: *p value for Kruskal-Wallis test comparing the three neuroplastic pattern changes after treatment. **Uniform pattern across all ROIs was considered if at least 11 out of 12 ROIs had the same direction of change in activation.
Regression analysis demonstrating a relationship between change in task-related regional brain activation and gain in skilled motor function (AMAT gain), adjusted for baseline AMAT, age and time since stroke.
| ROIs | Parameter estimate for motor function gain (AMAT, s), | Parameter estimate for baseline AMAT (s), | Parameter estimate for time since stroke (years), | Parameter estimate for age (years), | |
|---|---|---|---|---|---|
| 0.77 | 0.19 | −51.8 | 4.5 | ||
| ns | ns | ns | |||
| 0.87 | 0.28 | 169 | 2.8 | ||
| ns | ns | ns | |||
| 1.69 | 0.58 | 277 | 3.7 | ||
| ns | ns | ns | |||
| 1.08 | 0.33 | 264 | 1.0 | ||
| ns | ns | ns | |||
| 2.04 | 0.4 | 769 | 4.0 | ||
| ns | ns |
Listed here are parameter estimates for the model variables (and p values). Key: *Significant at p ≤ 0.05. ns, non-significant (.
Figure 5Relationship between motor function gain (AMAT score) and change in task-related brain activation in response to treatment. Key: M1, primary motor; LPM, lateral premotor region; S1, primary somatosensory area; SII, secondary sensory region; AMAT, Arm Motor Abilities Test.